Pharmaxis Ltd
ASX:PXS
Cash Flow Statement
Cash Flow Statement
Pharmaxis Ltd
| Jun-2013 | Jun-2014 | Jun-2015 | Jun-2016 | Jun-2017 | Jun-2018 | Jun-2019 | Jun-2020 | Jun-2021 | Jun-2022 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||
| Cash Taxes Paid |
0
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
3
|
2
|
41
|
1
|
3
|
(6)
|
1
|
7
|
21
|
3
|
|
| Cash from Operating Activities |
(35)
N/A
|
(28)
+20%
|
22
N/A
|
(12)
N/A
|
(15)
-27%
|
12
N/A
|
(20)
N/A
|
(13)
+33%
|
3
N/A
|
(16)
N/A
|
|
| Investing Cash Flow | |||||||||||
| Capital Expenditures |
(1)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
|
| Other Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Investing Activities |
(1)
N/A
|
(0)
+42%
|
(0)
+15%
|
(1)
-423%
|
(1)
+48%
|
(1)
-22%
|
(1)
-11%
|
(1)
+41%
|
(1)
-12%
|
(0)
+52%
|
|
| Financing Cash Flow | |||||||||||
| Net Issuance of Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
24
|
0
|
4
|
10
|
|
| Net Issuance of Debt |
18
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
|
| Other |
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(2)
|
(0)
|
(1)
|
(1)
|
|
| Cash from Financing Activities |
18
N/A
|
(1)
N/A
|
(2)
-32%
|
(2)
+4%
|
(2)
0%
|
(2)
-2%
|
21
N/A
|
(3)
N/A
|
2
N/A
|
7
+336%
|
|
| Change in Cash | |||||||||||
| Effect of Foreign Exchange Rates |
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
|
| Net Change in Cash |
(18)
N/A
|
(30)
-70%
|
20
N/A
|
(15)
N/A
|
(18)
-19%
|
10
N/A
|
0
-99%
|
(16)
N/A
|
4
N/A
|
(10)
N/A
|
|
| Free Cash Flow | |||||||||||
| Free Cash Flow |
(36)
N/A
|
(28)
+21%
|
22
N/A
|
(13)
N/A
|
(16)
-20%
|
11
N/A
|
(21)
N/A
|
(14)
+33%
|
2
N/A
|
(16)
N/A
|
|